Research programme: type 1 diabetes therapeutics - MultiCell Technologies
Alternative Names: MCT 275 Latest Information Update: 04 Nov 2017
At a glance Originator MultiCell Technologies Inc Class Mechanism of Action Immunosuppressants Orphan Drug Status No Highest Development Phases
No development reported Type 1 diabetes mellitus Most Recent Events
04 Nov 2017 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Parenteral, Injection) 24 May 2006 Preclinical trials in Type-1-diabetes-mellitus in USA (unspecified route)